ADVANCED LUNG CANCER
Clinical trials for ADVANCED LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED LUNG CANCER trials appear
Sign up with your email to follow new studies for ADVANCED LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Breathe in hope: new mRNA vaccine targets lung tumors
⭐️ VACCINE ⭐️ Recruiting nowThis early-phase study tests an inhaled mRNA vaccine called BMD006 for people with advanced lung cancer or solid tumors that have spread to the lungs. The vaccine is designed to train the immune system to attack tumor-related proteins. About 83 participants who have exhausted sta…
Matched conditions: ADVANCED LUNG CANCER
Phase: EARLY_PHASE1 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: ⭐️ VACCINE ⭐️
Last updated May 06, 2026 16:13 UTC
-
New drug targets Cancer's fuel line in first human trial
Disease control Recruiting nowThis early-phase study tests a new drug called BBO-10203 in people with advanced solid tumors (breast, colorectal, or lung cancer) that have not responded to standard treatments. The drug works by blocking a key cancer growth signal (PI3Kα:RAS). The main goals are to find a safe …
Matched conditions: ADVANCED LUNG CANCER
Phase: PHASE1 • Sponsor: TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics) • Aim: Disease control
Last updated May 17, 2026 00:26 UTC
-
New drug combo shows promise in shrinking advanced lung tumors
Disease control Recruiting nowThis study tests two experimental drugs, BNT324 and BNT327, together in people with advanced lung cancer that has spread or come back. The goal is to see if the combination can shrink tumors and control the disease. About 594 adults with small cell or non-small cell lung cancer w…
Matched conditions: ADVANCED LUNG CANCER
Phase: PHASE1, PHASE2 • Sponsor: BioNTech SE • Aim: Disease control
Last updated May 17, 2026 00:24 UTC
-
New hope for advanced lung cancer: TQB6411 trial launches
Disease control Recruiting nowThis study tests a new drug, TQB6411, in people with advanced lung cancer. The goal is to find the best dose and see if it can shrink tumors or slow the disease. About 465 adults aged 18 to 75 who are in fairly good health are being recruited. The drug is given by injection, and …
Matched conditions: ADVANCED LUNG CANCER
Phase: PHASE1, PHASE2 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New hope for advanced lung cancer: experimental combo trial launches
Disease control Recruiting nowThis study tests a new drug called MHB036C, given with other anti-cancer treatments, for people with advanced lung cancer that hasn't responded to standard therapies. The goal is to find the safest dose and see if it shrinks tumors. About 300 adults aged 18-75 with good performan…
Matched conditions: ADVANCED LUNG CANCER
Phase: PHASE1, PHASE2 • Sponsor: Minghui Pharmaceutical (Hangzhou) Ltd • Aim: Disease control
Last updated May 13, 2026 16:01 UTC
-
New app aims to help lung cancer survivors breathe easier and get stronger
Symptom relief Recruiting nowThis study is testing a mobile app called PROMOTE to help lung cancer survivors improve their physical function and overall wellness. The app provides support for managing breathlessness, sleep problems, physical activity, and diet. Researchers will enroll 250 people with stage I…
Matched conditions: ADVANCED LUNG CANCER
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated May 17, 2026 00:26 UTC
-
New study: app and nurse calls ease chemo side effects for cancer patients
Symptom relief Recruiting nowThis study tests whether a digital health platform, which includes a symptom-tracking app and a nurse-led phone program, can help cancer patients better manage chemotherapy side effects. About 414 adults with early or advanced stomach, lung, breast, or colon cancer will participa…
Matched conditions: ADVANCED LUNG CANCER
Phase: NA • Sponsor: Ulsan University Hospital • Aim: Symptom relief
Last updated May 14, 2026 12:06 UTC
-
New telehealth program aims to ease daily struggles for advanced cancer patients
Symptom relief Recruiting nowThis study tests a new program called ENGAGE, delivered via telehealth, to help people with stage IV breast, prostate, lung, or colorectal cancer better manage symptoms like pain, fatigue, and distress. About 190 participants will be randomly assigned to either ENGAGE or standard…
Matched conditions: ADVANCED LUNG CANCER
Phase: NA • Sponsor: Duke University • Aim: Symptom relief
Last updated May 14, 2026 12:04 UTC